The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Gallbladder Cancer: A Propensity Score-Adjusted, Population-Based Study. January 01, 2023 [MEDLINE Abstract] Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by ...
cytokine-induced memory-like (CIML) NK cells, which include increased expression of CD25 (IL-2Ra), decreased expression of KIRs, and Transforming Growth Factor-beta (TGFβ) receptors. These changes potentially alleviate inhibitory mechanisms in CIML NK cells. The enhanced production of Interferon-ga...
uncontrolled growth of abnormal cells that can affect any part of the body. Cancer can metastasize and spread to other organs if not detected at an early stage, making it a difficult disease to treat, resulting in a leading cause of death globally [1]. The World ...
Cancer Res Treat. 2005;37(1):20-23. doi:10.4143/crt.2005.37.1.20PubMedGoogle ScholarCrossref 135. Stegeman I, van Doorn SC, Mundt MW, et al. Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. Cancer ...
Oncol. Res. Treat. 39, 25–32 (2016). Article CAS PubMed Google Scholar Shlomai, J. Redox control of protein–DNA interactions: from molecular mechanisms to significance in signal transduction, gene expression, and DNA replication. Antioxid. Redox Signal. 13, 1429–1476 (2010). Article ...
Defining and using immune archetypes to classify and treat cancer In this Perspective, the authors suggest that different tumour microenvironments have ‘archetypal’ qualities across all cancers — characteristic and repeating collections of cells and gene-expression profiles at the level of the bulk tu...
Several treatment strategies have been designed to treat the never-ending rate of skin carcinoma. A void in the therapy regimen should be filled to facilitate cellular inhibition and apoptosis. The section below discusses the scope of the dermal therapeutic approach against skin cancer. ...
Cancer Treat. Rep. 70, 163–169 (1986). CAS Google Scholar Fu, F., Nowak, M. A. & Bonhoeffer, S. Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy. PLoS Comput. Biol. 11, e1004142 (2015). Article ADS Google Scholar Byrne, H...
Cancer Res. 49, 3457–3462 (1989). CAS PubMed Google Scholar Riesco-Eizaguirre, G. et al. The BRAFV600E oncogene induces transforming growth factor β secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Cancer Res. 69, 8317–8325 (2009). ...
Fatigue and pain are the most common side effects impacting quality of life (QoL) in cancer survivors. Recent insights have shown that perceived injustice (PI) can play a substantial role in these side effects, but research on cancer survivors is scarce.